Indivior Pharmaceuticals, Inc. INDV Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's financing cash flow?
- Indivior Pharmaceuticals, Inc. (INDV) reported financing cash flow of $7M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's financing cash flow changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's financing cash flow increased by 141.2% year-over-year, from -$17M to $7M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's financing cash flow?
- Over 2 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's financing cash flow has grown at a -45.5% compound annual growth rate (CAGR), from -$101M to -$30M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.